Zimbabwe Among 14 African Nations Facing Alarming Rise in Drug-Resistant Infections

By Staff Reporter  Results from a newly published study highlight the growing spread of drug resistance across 14 African countries, underscoring the urgent need to strengthen laboratory testing, data systems, and health planning to tackle hard-to-treat infections. The study, known as the Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP), is the largest of its kind ever conducted in Africa. It was led by a coalition including the Africa Centres for Disease Control and Prevention (Africa CDC), the African Society for Laboratory Medicine (ASLM), One Health Trust, and other regional partners.…

Read More

Zimbabwe Joins Rollout of First-Ever Oral Treatment for Deadly Sleeping Sickness

By Michael Gwarisa Zimbabwe is among five African countries that have started administering the world’s first all-oral treatment for Trypanosoma brucei rhodesiense sleeping sickness—a rare but deadly disease that has long affected communities in East and Southern Africa. The development marks a turning point in the fight against this neglected tropical disease, especially in endemic regions like Zimbabwe, where tsetse fly infestations remain a concern. The new drug, Fexinidazole Winthrop, is now being offered free of charge in specialized treatment centres in Zimbabwe, Malawi, Ethiopia, Tanzania, and Zambia. Its approval…

Read More